Stefan Bender,Lars Thore Burgdorf,Ulrich Emde,Norbert Beier,Johannes Gleitz,Christine Charon
申请号：
US12864348
公开号：
US08431602B2
申请日:
2008.12.23
申请国别(地区):
US
年份:
2013
代理人:
摘要：
Novel heterocyclic compounds of the formula Iin which R1, R2, R2′, R2″, R3, R4, R5, R6, R7 and R8 have the meanings indicated in Claim 1, are activators of glucokinase and can be used for the prevention and/or treatment of Diabetes Typ 1 and 2, obesity, neuropathy and/or nephropathy.
